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ABSTRACT:
Abundant epidemiological data shows that maternal smoking during pregnancy or 
second-hand smoke exposure during neonatal life and infancy increases the incidence of 
respiratory illnesses later in life. However, underlying mechanisms initiated in early life 
but affecting adult disease remain undefined. Neurotrophins, including nerve growth 
factor (NGF) and brain-derived neurotrophic factor (BDNF),  are neurotrophic factors 
essential in promoting and maintaining differentiation, growth, and survival of central 
and peripheral nervous system. The goal of this proposal is to examine the potential role 
of neurotrophin release in mediating long-term effects of prenatal and early postnatal 
smoke exposure. Our studies showed that an initial exposure to smoke during prenatal 
and early postnatal periods significantly changed lung function, substance P (SP) 
innervation in trachea and the level of NGF in BAL fluid after re-exposure to smoke on 
adult (postnatal day (PD) 60).  In controls, smoke exposure (PD 28) with a subsequent re-
exposure at PD 60 did not affect lung function or SP innervation or NGF levels. PCR 
array revealed enhanced expression of multiple genes including NGF and its receptor by 
smoke exposure only during early prenatal periods. These data suggest that a critical 
period of exposure exists in early periods of development.  Increased expression of NGF 
and its receptor in airway caused by smoke exposure may enhance susceptibility to 
respiratory illnesses in adult.   These findings have obvious and significant implication 
both for smoking during pregnancy and the effects of second hand tobacco smoke 
exposure.   The study provides evidence that prenatal and early postnatal life are periods 
of enhanced susceptibility to detrimental effects of cigarette smoke.  These effects appear 
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to be mediated through the release of neurotrophic factors like NGF which regulate 
growth and maturation of the airway during these susceptible periods.  
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  Epidemiological studies show that children of mothers who smoked cigarettes 
daily have increased probability of developing or exacerbating respiratory illnesses 1-3.
The nervous system, including the nerves supplying the airways, is highly susceptible to 
environmental influences during development.  Airway innervation develops rapidly 
during fetal and early postnatal life, parallel to the development of the lungs 4.   Given the 
dynamic and vulnerable nature of developmental processes, this period of morphogenesis 
is likely to be exquisitely sensitive to environmental insults 5.  Substance P (SP), a 
member of the tachykinin family, has potent effect on airway smooth muscle tone, 
vascular permeability to protein and mucus secretion 6-8.  SP can trigger symptoms of 
bronchial asthma, including airway hyperresponsiveness (AHR) and acute inflammation 
7-11.   Our recent studies demonstrated that increased SP levels in the airway was involved 
in smoke exposure-induced AHR12 and  that NGF released during irritant exposure, 
mediated the changes in phenotype and neuronal responses of airway neurons 13,14.   Joad 
and coworkers  showed that rats exposed to tobacco smoke in prenatal and early postnatal 
periods had increased airway responsiveness as adults compared to controls 15.  However, 
their studies did not separate prenatal and early postnatal periods from the later postnatal 
periods.   Thus, we hypothesized that a critical periods of sensitivity to smoke exposure 
exists within prenatal and early postnatal period, especially with respect to airway 
innervation.  In this study, we examine changes SP innervation  and neurotrophin 
expression in the airways and AHR after cigarette smoke exposures that occur during 
specific “critical period”.  
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Three different age groups of mice (embryonic days (ED) 7 by maternal exposure, 
postnatal days (PD) 2 and 21) were exposed either directly or indirectly to cigarette 
smoke or filtered air (sham smoke exposure).  The ED7 group was exposed indirectly by 
maternal exposure and the two PD groups were exposed directly.  Maternal or direct 
exposures lasted for 10 consecutive days (6 hours per day).  After the exposure periods, 
the mice were raised in normal animal housing and allowed to mature to postnatal day 59.  
On PD 59 all groups (both smoke exposed and controls) were re-exposed to smoke once 
for 6 hrs.  Lung function, SP innervation and NGF expression were measured at 24 hrs 
after re-exposure.  
There was no significant difference in the average baseline of lung resistance 
(RL) and dynamic pulmonary compliance (Cdyn) prior to methacholine (MCh) challenge 
between filtered air (control) and smoke exposure during prenatal or postnatal periods in 
the three different groups (Table 1). The MCh dose-response curves for RL were 
significantly elevated and Cdyn was significantly decreased in ED7 and PD2 smoke 
exposure groups (Figure 1) after the smoke re-exposure on PD 60.    However, there was 
no significant difference in the bronchomotor responses to MCh between PD21 air 
exposure and smoke exposure group after the smoke re-exposure.  The percent area of 
SP-IR nerve fibers in tracheal smooth muscle was significantly increased in the ED7 and 
PD2 smoke exposure groups.  SP nerve fiber density in trachea was significantly 
increased from 0.07% and 0.08% in ED7 and PD2 air exposure groups to 0.15% and 
0.16%, respectively, in the ED7 and PD2 smoke exposure groups (Figure 2 and 3) after 
the smoke re-exposure.  At the same time, SP nerve fiber density did not change 
significantly in PD21 groups, increasing only from 0.07% in PD21 air exposure animals 
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to 0.09% in PD21 smoke exposure animals (Figure 2 and 3). These findings suggest that 
the initial exposure to smoke during prenatal and early postnatal period significantly 
enhances the levels of SP in tracheal smooth muscle.  Similar effects were found in NGF 
released into BAL fluid. The concentrations of NGF in the BAL fluid were significantly 
elevated in the ED7 and PD2 smoke exposure groups after the smoke re-exposure. At the 
same time, the level of NGF was not significantly changed in PD21 groups (Figure 4) 
after the smoke re-exposure.  
Next, we test the effect of smoke during early postnatal period on changes of 
neurotrophins gene expression in lung. PD 2 mice were exposed to either smoke or 
filtered air for 10 consecutive days and neurotrophins gene expression was immediately 
measure after smoke exposure.  PCR array showed increased gene expression for NGF 
and the NGF receptor gene expression after smoke exposure during early prenatal 
periods.  A gene expression of second neurotrophin, BDNF, was not affected by smoke 
exposure (Figure 5).  While direct cause and effect was not determined in this study, 
previous studies in our laboratory have verified the close relationship between NGF 
expression and increased SP innervation after irritant exposures 13,16.
Recent studies have shown that infants and children exposed to irritants in early 
life have both immediate and persistent detrimental effects on lung health 17,18.  Airway 
sensitivity and airway responsiveness changed with age 19,20.   But, most of these studies 
focus on immune mechanisms that contribute to the development of airway diseases.  
Innervation of the airways and lung are not fully developed in the early postnatal stage of 
life. The sensitivity of airway nerves in newborns is less than adult levels21and the 
distribution and density of peptidergic nerves in young children is less than adults 22.
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Current results clearly show that prenatal and early postnatal life as a period of sensitivity 
to inhaled smoke.   Further, the present study found that SP nerve fibers in tracheal 
smooth muscle and NGF expression was significantly elevated, indicating that increased 
SP and NGF were may contribute to alteration of airway function which associate with 
enhancing susceptibility to respiratory illnesses in later life.
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Table 1. Effect of smoke on the baseline of RL (cm H2O/ml/s) and Cdyn (ml/cm H2O)  
                    Air                                                     Smoke                           
        RL                  Cdyn                                RL                     Cdyn  
  ED7                      1.12  r 0.11        0.053r0.014             1.18  r 0.19        0.046r0.016
  PD 2                   1.01  r 0.09        0.065r0.011             1.09  r 0.13        0.053r0.012                 
 PD 21                   1.08  r 0.05        0.062r0.008             1.02  r 0.10        0.069r0.011 
Data are meansrSE.    
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FIGURE LEGENDS
Figure 1.  MCh Dose responses of RL and Cdyn in prenatal (A and D), early postnatal (B 
and E) and late  postnatl (C and F)  filtered air (control) or smoke exposed  mice after the 
smoke re-exposure on PD 60. Values are means ± SE of 6 mice in each group. Peak 
response to each dose of MCh in each animal was averaged over 3 consecutive breaths. * 
Significant difference comparing corresponding data between control and smoke animals, 
P 0 0.05. 
Figure 2.   Fluorescence photomicrographs of substance P (SP)- -immunoreactive nerve 
fiber density within tracheal smooth muscle in prenatal filtered air (A) or smoke (B) 
exposure, early  postnatal (C) and late  postnatl (D) smoke exposure mice after the smoke 
re-exposure on PD 60. A (air exposure in prenatal period): negative SP-immunoreactive 
nerve in tracheal smooth muscle.  B (smoke exposure in prenatal period): increased SP-
immunoreactive nerve fibers in tracheal smooth muscle. C  (smoke exposure in early 
postenatal period): increased SP-immunoreactive nerve fibers in tracheal smooth muscle . 
D (smoke exposure in late postnatal period): Few SP-immunoreactive nerve fibers are 
present in tracheal smooth muscle.  Magnification: x285. 
Figure 3.  The changes of SP nerve fiber density in tracheal smooth muscle in prenatal 
(A),  early postnatal (B) and late  postnatal (C) filtered air (control) or smoke exposed 
mice after the smoke re-exposure on PD 60.  Values are means ± SE; n = 6 in each group. 
*Significant difference between control and smoke exposed mice, P 0.05. 
Figure 4.   The levels of NGF release in bronchoalveolar lavage fluid in prenatal (A),  
early postnatal (B) and late  postnatal (C) filtered air (control) or smoke exposed mice 
after the smoke re-exposure on PD 60.  Values are means ± SE; n = 6 in each group. NGF 
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was measured by ELISA.  * Significant difference between control and smoke exposed 
mice, P 0.05. 
Figure 5. The effect of smoke during early postnatal period on changes of neurotrophins 
gene expression in lung.
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